Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8552 |
High Similarity |
NPD1613 |
Approved |
0.8552 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8345 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8151 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8084 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8082 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8041 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7917 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7877 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.784 |
Intermediate Similarity |
NPD1934 |
Approved |
0.784 |
Intermediate Similarity |
NPD37 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7697 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD4663 |
Approved |
0.76 |
Intermediate Similarity |
NPD7309 |
Approved |
0.759 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7558 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7557 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7543 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7533 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD7472 |
Approved |
0.75 |
Intermediate Similarity |
NPD7340 |
Approved |
0.75 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7485 |
Intermediate Similarity |
NPD27 |
Approved |
0.7471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7431 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7412 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7288 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7284 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7256 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7238 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7168 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD3750 |
Approved |
0.716 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7159 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7152 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD7985 |
Registered |
0.711 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7016 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7016 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7013 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7011 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD4481 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD4675 |
Approved |
0.6982 |
Remote Similarity |
NPD4678 |
Approved |
0.6981 |
Remote Similarity |
NPD3657 |
Discovery |
0.6977 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6963 |
Remote Similarity |
NPD4002 |
Approved |
0.6963 |
Remote Similarity |
NPD4004 |
Approved |
0.6961 |
Remote Similarity |
NPD8312 |
Approved |
0.6961 |
Remote Similarity |
NPD8313 |
Approved |
0.6959
|
Remote Similarity |
NPD8455 |
Phase 2 |